🇺🇸 FDA
Pipeline program

A Phase 1 Study of TAS0612 in Patients with Locally Advanced or Metastatic Solid Tumors

TAS0612-101

Phase 1 other active

Quick answer

A Phase 1 Study of TAS0612 in Patients with Locally Advanced or Metastatic Solid Tumors for Locally Advanced or Metastatic Solid Tumors is a Phase 1 program (other) at Taiho Pharma Netherlands B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Taiho Pharma Netherlands B.V.
Indication
Locally Advanced or Metastatic Solid Tumors
Phase
Phase 1
Modality
other
Status
active

Clinical trials